Life Science Medical Technology Pharmaceuticals 
Health Populi
APRIL 6, 2022
For wonky-tech readers, this involves using Seqster’s proprietary technology (FHIR+) to enable the flow of patient information from once-siloed data locked into legacy systems and wearable tech clouds.
Health Populi
APRIL 1, 2022
To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. To scale what works, based on evidence and proven interventions — which depends on our reducing biases in our assumptions, models and strategies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
DECEMBER 27, 2021
That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.
Healthcare IT Today
NOVEMBER 15, 2022
CitiusTech , a leader in healthcare technology and consulting services, today announced that it has acquired Wilco Source , one of the world’s leading providers of Salesforce consulting and implementation services for healthcare and life sciences companies. patient and provider portals) (Salesforce Communities).
Digital Health Global
MARCH 5, 2025
The newly appointed board members are: Jennifer Chavez, Senior Director, BioMed Realty Provides comprehensive commercial real estate transaction expertise and specialized business management services for BioMed Realtys Colorado portfolio, including the 23-building Flatiron Park, a hub for life science, quantum and technology innovation.
Digital Health Global
FEBRUARY 5, 2024
Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science.
Digital Health Global
MARCH 16, 2023
The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.
Expert insights. Personalized for you.
436 
Let's personalize your content